Index of reports
> Cases with Death (9)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Epirubicin side effects in 35 year old female
Reported by a physician from Philippines on 2012-08-16
Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Dosage: form:vialtotal dose recieved:140 mg
Start date: 2010-11-04
Docetaxel
Dosage: form:vialtotal dose recieved:152 mg
Start date: 2010-09-02
Trastuzumab
Dosage: form:vialtotal dose recieved:336 mg
Start date: 2011-07-21
Fluorouracil
Dosage: form:vial
Start date: 2010-11-04
Trastuzumab
Dosage: form:vial
Cyclophosphamide
Dosage: form:vialtotal dose recieved:936 mg
Start date: 2010-11-04
Possible Epirubicin side effects in 35 year old female
Reported by a physician from Philippines on 2012-08-09
Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Trastuzumab
Dosage: form:vial
Epirubicin
Dosage: form:vialtotal dose recieved:140 mg
Start date: 2010-11-04
Trastuzumab
Dosage: form:vialtotal dose recieved:336 mg
Start date: 2011-07-21
Docetaxel
Dosage: form:vialtotal dose recieved:152 mg
Start date: 2010-09-02
Cyclophosphamide
Dosage: form:vialtotal dose recieved:936 mg
Start date: 2010-11-04
Fluorouracil
Dosage: form:vial
Start date: 2010-11-04
Possible Epirubicin side effects in 35 year old female
Reported by a physician from Philippines on 2012-06-01
Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Fluorouracil
Dosage: form:vial
Start date: 2010-11-04
Trastuzumab
Dosage: form:vialtotal dose recieved:336 mg
Start date: 2011-07-21
Docetaxel
Dosage: form:vialtotal dose recieved:152 mg
Start date: 2010-09-02
Epirubicin
Dosage: form:vialtotal dose recieved:140 mg
Start date: 2010-11-04
Cyclophosphamide
Dosage: form:vialtotal dose recieved:936 mg
Start date: 2010-11-04
Trastuzumab
Dosage: form:vial
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-18
Patient: 49 year old female
Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Multi-Organ Failure, Death, Lymphocytosis, Dizziness, Asthenia, Septic Shock, Leukocytosis, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytoxan
Dosage: 100 mg, unk
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Epirubicin
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Fluorouracil
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-15
Patient: 49 year old female
Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Lymphocytosis, Multi-Organ Failure, Death, Dizziness, Septic Shock, Asthenia, Leukocytosis, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Fluorouracil
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Epirubicin
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Possible Epirubicin side effects in female
Reported by a physician from Finland on 2012-04-23
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1
Indication: Breast Cancer
Capecitabine
Dosage: first dose administered on day 1 evening and last dose administered on day 15 morning every 3 weeks.
Administration route: Oral
Indication: Breast Cancer
Docetaxel
Dosage: on day 1 as 1-hr intravenous infusion
Indication: Breast Cancer
Epirubicin
Dosage: on day 1
Indication: Breast Cancer
Capecitabine
Dosage: first dose administered on day 1 evening and last dose administered on day 15 morning every 3 weeks.
Administration route: Oral
Other drugs received by patient: Corticosteroids
Possible Epirubicin side effects in female
Reported by a physician from Finland on 2012-04-23
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Dosage: on day 1
Indication: Breast Cancer
Docetaxel
Dosage: on day 1 as 1-hr intravenous infusion
Indication: Breast Cancer
Cyclophosphamide
Dosage: on day 1
Indication: Breast Cancer
Fluorouracil
Dosage: on day 1
Indication: Breast Cancer
Other drugs received by patient: Corticosteroids
Possible Epirubicin side effects in 35 year old female
Reported by a physician from Philippines on 2012-04-02
Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Trastuzumab
Dosage: form:vialtotal dose recieved:336 mg
Start date: 2011-07-21
Fluorouracil
Dosage: form:vial
Start date: 2010-11-04
Trastuzumab
Dosage: form:vial
Epirubicin
Dosage: form:vialtotal dose recieved:140 mg
Start date: 2010-11-04
Cyclophosphamide
Dosage: form:vialtotal dose recieved:936 mg
Start date: 2010-11-04
Docetaxel
Dosage: form:vialtotal dose recieved:152 mg
Start date: 2010-09-02
Possible Epirubicin side effects in 68 year old female
Reported by a physician from Japan on 2012-03-27
Patient: 68 year old female
Reactions: White Blood Cell Count Decreased, Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer
Start date: 2012-02-28
End date: 2012-02-28
Cyclophosphamide
Indication: Breast Cancer
Start date: 2012-02-28
End date: 2012-02-28
|